{"id":"NCT01721954","sponsor":"Sirtex Medical","briefTitle":"FOLFOX6m Plus SIR-Spheres Microspheres vs FOLFOX6m Alone in Patients With Liver Mets From Primary Colorectal Cancer","officialTitle":"Assessment of Overall Survival of FOLFOX6m Plus SIR-Spheres Microspheres Versus FOLFOX6m Alone as First-line Treatment in Patients With Non-resectable Liver Metastases From Primary Colorectal Carcinoma in a Randomised Clinical Study","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2013-05-01","primaryCompletion":"2016-12-23","completion":"2017-02-28","firstPosted":"2012-11-06","resultsPosted":"2019-10-22","lastUpdate":"2019-11-05"},"enrollment":209,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Colorectal Cancer Metastatic"],"interventions":[{"type":"DRUG","name":"FOLFOX6m","otherNames":[]},{"type":"DEVICE","name":"SIR-Spheres microspheres","otherNames":[]}],"arms":[{"label":"Control Arm","type":"ACTIVE_COMPARATOR"},{"label":"Experimental Arm","type":"EXPERIMENTAL"}],"summary":"This study is a randomized, multi-center study that will compare the efficacy and safety of selective internal radiation therapy (SIRT) using SIR-Spheres microspheres plus a standard chemotherapy regimen of FOLFOX6m versus FOLFOX6m alone as first-line therapy in patients with non-resectable liver metastases from primary colorectal carcinoma.\n\nTreatment with the biologic agent bevacizumab, if part of the standard of care at participating institutions, is allowed within this study at the discretion of the Investigator.","primaryOutcome":{"measure":"Overall Survival (OS)","timeFrame":"From date of randomization until the date of death from any cause assessed up 3 yrs 8 months","effectByArm":[{"arm":"mFOLFOX6 Plus SIRT","deltaMin":25.9,"sd":null},{"arm":"mFOLFOX6 Alone","deltaMin":25,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"0.43"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":9,"exclusionCount":9},"locations":{"siteCount":83,"countries":["United States","Australia","Belgium","France","Germany","Israel","Italy","New Zealand","Portugal","Singapore","South Korea","Spain","Taiwan"]},"refs":{"pmids":["26903575","31840815","28781171","28351831"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":47,"n":92},"commonTop":["Neuropathy peripheral","Nausea","Fatigue","Diarrhoea","Neutropenia"]}}